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Statement of Disclaimer  
Since this project is a result of a class assignment, it has been graded and accepted as fulfillment 
of the course requirements. Acceptance does not imply technical accuracy or reliability. Any use 
of information in this report is done at the risk of the user. These risks may include catastrophic 
failure of the device or infringement of patent or copyright laws. California Polytechnic State 
University at San Luis Obispo and its staff cannot be held liable for any use or misuse of the 
project. 
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1.0 Executive Summary 
PLGA is used to create three dimensional porous scaffolds that play a crucial role in 
osteoblast proliferation. This technique can be helpful for cell transplantation and other bone 
research applications [5]. The properties of the scaffolds may cause them to float in the 
surrounding media, exposing the top surface to air where cells can’t proliferate effectively. The 
purpose of the PLGA Scaffold Device is to submerge the scaffolds in the cell media to promote 
cell growth and proliferation. While achieving this main goal, the device also had satisfy several 
customer requirements such as being biocompatible, sterilizable and able to survive incubation. 
A final design was chosen to replace the lid of the well plate to submerge the scaffolds. Cell 
proliferation, autoclave and incubation tests were performed to ensure previously customer 
requirements were met. This document overviews the development of a cost effective device that 
will work in combination with a well plate to keep the scaffolds submerged. 
 
2.0 Introduction and Background 
The purpose of the PLGA Scaffold Project is to design a device that keeps PLGA 
scaffolds completely submerged in a cell nutrient medium for up to three weeks. The submersion 
of the scaffold will lead to greater cell proliferation and growth on the top surface of the scaffold.  
This device is being designed for Christopher Heylman bone tissue engineering research efforts.  
This document will overview existing products and patents similar to our device and why 
there is a need for such devices. We will also discuss our customer requirements, translated into 
engineering specifications, and corresponding relevant standards and codes. We will lay out 
initial plans for the design process and how we want to manage the project over the next quarter.  
 
Current Products: 
There are several current products on the market that address flotation of scaffolds in the 
cell medium. Thermo Fisher Scientific Cell Culture Inserts for Skin Tissue Culture includes a 
well plate with polycarbonate membrane inserts. There are 3 different height ranges for the 
inserts. A case of twenty-four 6-well plates with inserts included costs $181. 
 Master bond has a MB250NT glue which is an cyanoacrylate that is non-toxic and 
adheres with ISO-10993. The glue can be used to adhere scaffolds to the well plate. MB250NT 
glue adheres to ISO-10993 standards, cures rapidly and is resistant to gamma sterilization. A two 
ounce bottle of MB250NT glue costs $40.  
In several experiments, researchers have placed stainless steel rings on top of scaffolds to 
keep the submerged. In one study, the stainless steel ring was made by the University of 
Nottingham[3]. The estimated cost of the stainless steel ring is $50.  
Falcon Cell Culture Inserts have a porous membrane on the bottom of the insert. The 
membrane has two pore size options and two pore density options. The inserts are low protein 
binding,sterilized by gamma irradiation and cost $248 for forty-eight cell culture inserts. 
 Cell Crown24NX inserts are made from a polycarbonate material, available for 12 and 
24 well plates, the height of th inserts can be adjusted, they can be delivered gamma-irradiated or 
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non-sterile. The main difference in this project is the insert, sandwiches the material and can 
completely submerge the sample in the cell medium. 
The products above were difficult to find online, which implies they are not widely used. 
In numerous research papers the scientists, would design their own device to keep the scaffold 
submerged. This also implies that an adequate product has not yet been designed that allows for 
ideal cell proliferation and keeps the scaffold completely submerged. The previous products 
could help us brainstorm different design ideas or expand and improve the designs already on the 
market. 
 
Patents: 
 Table 1: Patent Information on Scaffold Stabilization Methods and Devices 
Patent Characteristics 
US5578492A 
 
Cell Culture Insert[7] 
● Cell supporting membrane separation 
device 
● Support mechanism for holding 
scaffold suspended in medium 
● Break-away mechanism to separate 
from the support mechanism  
US6468788B1 
 
Method and Device for Accommodating a 
Cell Culture[10] 
● Vessel has base, walls and lid 
enclosing scaffold in cell medium 
● Evacuation opening on lid for excess 
liquid and displaced air 
CN106367347A 
 
Biological Support Material Fixed Mount[2] 
 
 
● Biological scaffold bracket including a 
fixed portion, and a controllable 
vertical bracket portion 
●  A vertical portion connecting the 
fixed bracket and control unit 
● A controllable portion rotatably 
connected on the upright support,  
● Grooves along the controllable portion 
help hold each scaffold in the slot on 
the controlled portion 
CN103396935A 
Biological Scaffold Material Fixing Rack[11] 
 
● Vertical support section again cell wall 
● Two ring arm encompassing scaffold 
● Adjustable ring size and height 
● Spring vertical bracket hung above 
medium to hold vertical support in 
place 
WO2017141531A1 
 
● Scaffold holding plate 
● Movable component that holds the 
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Method for Seeding Cells to Scaffold 
Material[12] 
 
 
syringe with the cell medium 
● Needle has multiple discharge points 
● Syringe is movable forward and 
backwards 
 
Table 1 shows five patents for securing biological scaffolds and ensuring they do not 
float. Each patent has a different approach to achieving this goal. The Method and Device for 
Accommodating of a Cell Culture patent is basically a cage that contains the scaffold and keeps 
it submerged in the cell medium. The Method for Seeding Cells to Scaffold Material patent is 
seeding cells with a syringe therefore eliminating the need for submersion in a cell medium. The 
Cell Culture Insert is similar to the Cell Crown24NX inserts described in the previous section of 
Current Products.  
 
Technical References: 
The purpose of tissue engineering is to re-establish or mimic the function and output of a 
tissue or organ. The basis of tissue engineering involves cells and a scaffold. In almost all cases 
cells cannot simply be injected into the damaged tissue or organ to restore function. Scaffolds are 
used to support cell growth, proliferation just as the extracellular matrix does. A scaffold placed 
in the body at the point of regeneration can also serve to protect the site of action from attacking 
cells in the body[6].  
There are around 1 million individuals with a skeletal defect requiring a bone graft every 
year. Tissue engineering efforts focusing on bone are trying to eliminate the need for autologous 
grafts and allografts. Autologous grafts are limited due to donor site morbidity and the limited 
amount of bone that can be excised[9]. 
Scaffolds have to meet certain requirements to effectively allow for cell growth and 
proliferation. The pore size of scaffolds is important because it affects the mechanical strength of 
the scaffold the pores also need to adequately sized for nutrients, waste and gases to move 
through the scaffold[9]. The pores also need to be interconnected to form a network that allows 
for the cells to proliferate throughout the whole scaffold.  The rate of degradation of the scaffold 
is also important and dependent on the tissue being regenerated. The degradation rate of a 
scaffold for the skeletal system would be slow to allow for the bone to heal and grow. If a 
scaffold remains longer than needed, it could negatively affect the cell growth and function of 
the native tissue[6]. 
The gas-foaming method is used to create PLGA scaffolds. For this method, sodium 
bicarbonate,a foaming agent, is added to the polymer phase of PLGA. This mix is compressed 
into a disk and placed in a compression chamber with 𝐶𝑂2. The gas phase  rises to the surface of 
the structure, while the liquid phase sinks to the bottom. Once the gas has completely left the 
polymer, a porous structure remains due to the gas particles.The top of the scaffold tends to be 
more porous due to the gas diffusing up and the bottom of the scaffold tends to be less dense due 
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to the liquid moving down due to density differences[4]. The sodium bicarbonate is then leached 
out of the scaffold to ensure the outer layer of the scaffold is porous and the pores are 
interconnected [1]. The foam is then stabilized with the addition of a surfactant. The surfactant 
also prevents liquid from draining from the scaffold [4]. 
PLGA is widely used in tissue engineering of bone due to its controllable degradation 
rate and biocompatibility. Both lactic acid and glycolic acid are naturally occurring. Once the 
scaffold is degraded, both acids are removed from the body through natural pathways [5].PLGA 
is a copolymer of poly lactic and co-glycolic acid formed through a condensation reaction. 
PLGA is widely used due to its controllable degradation rate. This is determined by the ratio of 
glycolic acid to lactic acid. Lactic acid is more hydrophobic which leads to fewer ester linkage 
breaks and a slower degradation rate. A limitation of PLGA is that it does not perform very well 
in load bearing situations due to its significantly lower Young’s Modulus than bone [8]. 
Knowledge of the purpose of tissue engineering scaffolds, the procedure to make them 
and the ideal properties of the scaffold will give our group a more comprehensive outlook and 
perspective on PLGA scaffolds. Porosity, pore size and degradation are important for scaffolds 
to proliferate cells and grow cells. For our design, we now know our device should not adversely 
affect these properties. Other information from these technical papers will help us later on in the 
design stages when we have a more definitive direction. 
 
Project Specific Information: 
 During the first week, the PLGA Scaffold group met with Dr. Heylman and discussed the 
details of his bone research lab. We learned the PLGA scaffolds are around 5 mm in height and 
that the PLGA scaffold procedure includes incubating the scaffolds for a maximum of three 
weeks. After hearing that the device would be incubated, material selection became a high 
priority. Designs that were found in research articles were discussed with Dr. Heylman and he 
said his lab had considered a cage design for the device to keep the scaffolds submerged. 
Information specifically regarding Dr. Helman’s PLGA Scaffolds will help us create a design 
that is tailored to his lab and procedure. 
 
Standards, Codes and Regulations: 
ISO 10993 
ISO 13485 
MSDS 
Approved Biomaterials List 
Standards put out by CDER, CBER and CDRH 
GLP and GMP 
 
 
 
3.0 Customer Requirements and Design Specifications 
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3.1 IFU 
A method to ensure the entire scaffold is submerged and/or exposed to medium. This 
method will be used for tissue engineering applications to ensure scaffold submersion in media 
to promote cell growth throughout the scaffold. 
 
3.2 Product Design Specifications 
Table 2: PDS matrix for our PLGA scaffold device.  
Customer 
Requirement 
Engineering Metric Specification Rationale 
Must be sterile and 
portable enough to be 
placed in humidified 
cell culture incubator  
Must withstand 5% 
CO2 and 37°C 
incubation 
environment 
No temperature 
warping at 37°C in 
humidified 
environment 
Must survive 
temperature similar to 
human body to allow 
accurate osteoblast 
growth.  
Must be cost effective Low Cost  Under $5 The allocated budget 
is set from the class 
requirements  
Must be disposable 
or, if reusable, must 
be sterilizable 
Approved 
biomaterial, can be 
autoclaved 
No change in 
dimensions after 
autoclave 
Many scaffolds will 
be used. Reused 
scaffold supports 
must be sterile to 
allow proper cell 
growth.  
Must survive 
throughout entire 
incubation 
No degradation 
anywhere from 7 days 
- 3 weeks  
Keep X% of UTS 
after 3 weeks of 
media contact 
Degraded scaffold 
will alter cell growth 
patterns midway 
through incubation.  
Must allow for cell 
proliferation on top 
layers of scaffold 
Small contact area 
with scaffold 
Contact area less than 
5 mm2 per scaffold 
To promote 
maximum cell growth 
in the scaffold. 
Must be able to attach 
to well plate 
Similar length and 
height of well plate 
Fit around well plate 
with 1.5 mm or less 
in clearance  
To stabilize the 
device on the well 
plate to avoid 
movement of the 
scaffolds. 
 
 
3.3 House of Quality 
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Table 3: HoQ rooms 1, 2, & 4. 
 Engineering Specifications 
Improvement 
Direction 
n/a ↑ ↓ ↓ ↓ ↑ 
Units n/a MPa $ mm^2 in or mm lb 
Custome
r 
requirem
ent 
Impor
tance 
factor 
Biocompatible 
material 
Material 
strength 
Low 
cost 
Small 
contact 
area 
Dimensions 
within 1” of 
well plate 
Weight 
Steriliza
ble or 
reusable 
5 9 3     
Cost 
effective 
3 3  9   9 
Survive 
incubatio
n 
5 3 9     
Allow 
top 
surface 
prolifera
tion 
4    9 1  
Attach to 
well plate 
4     9 1 
Raw 
Score 
263 69 60 27 36 40 31 
Relative 
Weight 
% 
100 26.2 22.8 10.3 13.7 15.2 11.8 
Rank 
Order 
- 1 2 6 4 3 5 
 
 
 
Table 4: HoQ room 3 screenshot from excel. 
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Table 5: HoQ room 6. 
COMPETITOR RANKINGS 
1-Poor, 3-OK, 5-Excellent 
CR CellCrown 24 NX 
Well Inserts 
Master Bond 
Cyanoacrylate  
Our Device 
Sterilizable or Reusable 1 2 4 
Attach to Well Plate 5 4 5 
Allow top surface for 
Proliferation 
3 3 4 
Biocompatibility 5 5 5 
Cost Effective 3 3 3 
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Survive Incubation 3 5 5 
 
4.0 Stage Gate Process 
 
A PERT chart was created at the beginning of this quarter to determine what tasks needed 
to be completed and when to finish the project on time. The critical path is mainly determined by 
class presentations. Our PERT chart ends with two deliverables: the Final Design Presentation 
and the final report. The next tasks on our critical path are the Manufacturing Plan, Material 
Selection, and Design Freeze Presentation. To complete these tasks, dimensions for our device, 
details of the design and clear, chronological manufacturing instructions will need to be 
completed. The PERT chart can be referenced below in Appendix B. 
 
 4.1 Concept Review 
For our project three main designs were considered. The first design was an external 
device with a large base and prongs. The prongs would have tips that are in contact with the 
scaffolds and submerge them in the cell medium.The top of the device would serve as the well 
lid and the legs of the device would attach to a base below the well plate. This concept allows 
contents of all wells to be submerged simultaneously.  
The second design was a semipermeable membrane spherical shape with a 
semipermeable lid. A handle would attach to the semipermeable membrane and hook onto the 
well. The semipermeable membrane would allow for the scaffold to have contact with the 
medium and remain submerged. This design would require a device for each individual well. 
This concept requires tedious setup but allows all scaffolds to be submerged and removed 
simultaneously.  
The third design was a bioreactor. The bioreactor would be enclosed in a container and 
have one flow chamber. The flow would be in the direction of gravity and would flow through a 
funnel shape that would be larger at the top than the bottom. The fluid flow would serve to keep 
the scaffold submerged in the cell medium without constant media change. Each scaffold would 
have to have its own cell in the bioreactor. This design is significantly more expensive but 
negates the need for a well plate or constant media change.  
PUGH charts were made comparing each design to a current product on the market, Cell 
Crown24NX inserts, and comparing each design to each other. The PUGH charts can be 
referenced below in Appendix E. The net number of positives for each design was assessed and a 
front runner concept of the external device with a large base and prongs was selected. 
 
 
 4.2 Design Freeze 
The first design was chosen, with reference to Concept Review, and designed in 3D 
modeling software, Solidworks. The design was demonstrated as replacement to the lid to work 
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in conjunction with the already existing well plate. The design was made to physically push the 
scaffolds into the media, forcing the entire scaffold to rest in the media. The prongs were varied 
in size and amount for variation in determining the highest efficacy for cell growth.  
 
 4.3 Design Review 
 An effective base thickness was needed to correspond with the 3D printers effects on the 
material. The prongs were increased by .5 mm in diameter for a higher efficacy in printing. 
Lastly, the optimal number of prongs and size was determined to be n=3 prongs and 1.5mm 
diameter, 7.0 DOE.  
 
5.0 Description of Final Prototype Design  
 
5.1 Overview 
The device will be composed of all Nylon PA 6 and replace the lid of the well plate. It 
will be designed to be the same basic size as a normal well plate lid. Prongs attached to the 
underside of the lid will project into each well and hold down the scaffolds. Each ‘prong’ 
consists of solid cylinder base projecting from the lid with smaller cylinders projecting off the 
base cylinder. These small cylinders will be in contact with the scaffold. It will be intended for a 
48-well plate and have 48 prongs.  
 
5.2 Design Justification 
 Tolerances were given from the Ultimaker printer manufacturer website. All dimensions 
in the drawing are millimeters. The device will be printed upside down so that the prongs will 
project from the lid upwards. SolidWorks drawings can be seen in appendix C.  
 
5.3 Analysis 
Using original lid design measurements will ensure a secure fit over the well plate and 
maintain a small size. The device will be one solid piece to increase its durability. Initial 
prototypes proved that minimum prong diameter must be at least 1.5 mm for proper printing. The 
smallest possible diameter should be used to minimize surface contact with the scaffold.  
 
 
 
 
 
 
 
 
5.4 Cost Breakdown 
Table 6: Bill of materials. 
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Product Distributor Cost Unit Amount Details 
Product 
Number For 
Nylon 6 3D Universe 40.49 each 1 
750 g spool of 
2.85 mm 
filament 
KODAK_N
Y63NON Manufacturing 
Garolite 
sheet 
McMaster 
Carr 6.82 each 1 
12" x 12" 1/32" 
thick 9910T11 Manufacturing 
Ultimaker 
3 3D 
Printer 3D Universe 
3495.0
0 each 1 
Complete 3D 
Printer UM3 Manufacturing 
 
We have approved access to the 3D printer, the spectrophotometer, and the autoclave. We will 
not need to spend money on manufacturing or testing besides the materials. Everything thing can 
be done at Cal Poly with help from students and faculty.  
 
5.5 Safety Considerations 
The device will contain small detailed design that can lead to sharp edges or prongs 
breaking off. The sharp edges are smoothed after the autoclave process, so the device should be 
handled carefully or with gloves before the sterilization. Prongs should never be pushed or 
touched with fingers to prevent damage to the smaller parts.  
 
6.0 Prototype Development 
 
6.1 Model Analyses 
Manufacturing of our device was done in a lab containing a Ultimaker 3 3D printer. No 
outside manufacturing services were needed. Our parts were machined printed to size. Our 
device contains many small parts which could be difficult to manufacture. Also, tolerances of the 
prong diameters and spacing are important to ensure each prong lines up over a specific well.  
The tip design of our prongs were further developed. We wanted to minimize media 
displacement and scaffold surface contact. Therefore we altered the tip where it contacts the 
scaffold, for efficacy of 3D print and connection with the scaffold. 
 
 
 
 
 
6.2 Evolution of Prototypes 
The original prototype contained a large variety of prong types and prong lengths. The 
first prototype consisted of many manipulations that weren’t consistent with 3D CAD design.  
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The second prototype increased the base thickness for printing efficacy. The purpose was 
due to warping of the base portion. The diameters of the prongs were all increased by .5 mm in 
diameter to increase the efficacy of print. Therefore all prongs had either a 1.5 mm or 2 mm 
diameter.  
The final functional prototype contained a range of diameters and amount of prongs in 
order to determine the best configuration for cell growth.  
 
6.3 Manufacturing Process 
The manufacturing process consisted of 3D printing the CAD design with Nylon PA 6 on 
an Utilmaker 3 3D printer.  
 
MPI 
1.) Purchase 2.85 mm Nylon PA 6 
2.)  Save part file “Scaffold_Lid.sldprt” as an .stl file 
3.)  Save SW file on USB/SD card or send to printer operator 
4.)  Load Nylon PA 6 into the Ultimaker 3 
 -On the printer select ‘material’ -> ‘change’ 
 -Wait while nozzle heats up, filament will start retracting automatically 
 -Once printer says ‘Insert New Material’ place spool so it spins CW as it is used 
 -Press ‘continue’ 
5.)  Place Garolite Sheet on glass bed 
6.)  Program heating bed and printer to desired printer settings 
-Print temp 240-280C 
-Print bed 90-120C, not glass 
-Cooling fans: off 
-Slow speed (<40 mm/s) for first ten layers to avoid warping 
7.) Print for specified time according to Ultimaker 3 display 
 
 
 
 
 
 
 
 
 
 
Table 7: Design history record. 
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Step # Deviation from MPI Date Performed Signature 
1 N/A 1/15/19 Bryce 
2-3 N/A 1/29/19 Tyler 
4 Printed on masking 
tape, not garolite* 
1/30/19 Tyler 
5-7 N/A 1/30/19 Tyler 
5-7 N/A 2/2/19 Tyler 
5-7 N/A 2/7/19 Tyler 
5-7 N/A 2/28/19 Tyler 
5-7 N/A 3/17/19 Tyler 
*The Garolite sheet was not large enough to cover the entire print bed, layers of masking tape 
worked well.  
 
6.4 Divergence Between Final Design and Final Functional Prototype 
 The final design and the final functional prototype will be made using the exact same 
manufacturing process. The only difference is that the final design will have uniform prongs that 
are all exactly the same. The final functional prototype has multiple prong types that differ in 
size and the number of contact points, which will be evaluated during the final cell proliferation 
testing. The final design will be made using the single prong design that allows the most cell 
growth.  
 
 
 
7.0 IQ/OQ 
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7.1 DOE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7.2 Verification and Validation 
Cell proliferation testing 
Two cell proliferation tests will be performed. One test will be with performed 
using NIH-3T3 fibroblasts without scaffolds or our device. The other test will use our 
device and have cells seeding on scaffolds. Both tests will use a 48 well plate, liquid 
nutrient media, and proliferation will be quantified using a CCK-8 assay from Sigma 
Aldrich.  
 
NIH-3T3 Testing 
Equipment: 48 well plate, NIH-3T3 cells, nutrient media, CCK-8 assay, micropipette, 
gloves, 15 mL conicals, DI water 
Location and time: 192-328 (plating and incubation) and 33-394 (absorbance 
measurement) on Friday 3/1/19 from 8-11 a.m. Cells were plated the previous wednesday 
around 12 noon.  
Procedure: 
1.) Obtain all equipment and sterilize if necessary.  
2.) Plate NIH cells onto the plate according to the following: 
 -Six wells are used for each of the five concentrations, totaling 30 wells.  
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 -Concentrations used are: 6250, 12500, 25000, 50000, & 100000 cells per well. 
3.) Once plated, pipette 0.50 mL nutrient media into each well with NIH cells.  
4.) Cover well plate with well plate lid and place in incubator at 37°C, 5% CO2 for 44 
hours.  
5.) Remove plate from incubator, remove lid, and add 30 microliter of CCK-8 cellular 
assay to each well with cells and media.  
6.) Fill a 15 mL conical with 3.0 mL DI water and 30 mL CCK to act as a control.  
7.) Place well plate and conical with DI water in incubator for 3.5 hours. Remove well 
plate. 
8.) For wells of the same concentration, pool each of the six wells into a 15 mL conical 
using a pipette. (fig.1)  You should now have five 15 mL conicals each with 3.0 mL of 
sample, as well as the one with water from step 6.  
9.) Cover the conicals with tinfoil and take them to the spectrophotometer.  
10.) Fill another conical with DI water and auto-zero the spectro at 460 nm: 
 -Turn on machine. 
 -Select ‘Spectra Manager’ -> ‘Time Management’ 
 -Place cuvette with water in spectro.  
 -Select ‘Parameters’ -> ‘Auto-zero’, and enter 460 nm for wavelength. 
11.) Empty conical into a clean and dry cuvette being sure not to introduce any bubbles. 
(fig.1)   
12.) Take a ten second measurement of the sample and record average absorbance.  
13.) Repeat steps 11-12 for each sample.  
 
 
 
 
Figure 1: Spectrophotometer, well plate, CCK product, and conical with sample used for NIH 
testing.  
 
 
 
NIH-3T3 Test Results 
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Results from the first NIH run were not used. The cells proliferated so much that each well 
exceeded the recommended working range for the assay, which is 5000-50000 cells per well. For 
the next run, the cells were plated only two days before testing. Example results from the 
program as well as absorbance values from the test can be seen below. Results from this test 
were as expected: absorbance of media with CCK assay increases linearly with cell quantity. 
 
Figure 2: NIH-3T3 assay results. Both screenshots show results for highest 100000 cells/well. 
True average absorbance  can be seen at the top left of the screenshot in red text. 
 
  
 
 
Table 8: All NIH test results. 
Cells/well Total cells in 
3.0 mL sample 
Absorbance  
Control (CCK 
in DI water) 
0 -0.003 
6250 37500 0.763 
12500 75000 1.081 
25000 150000 1.713 
50000 300000 2.212 
100000 600000 2.870 
Significance: PASS, CCK-8 cellular assay proved to be accurate in determining cellular 
proliferation based on absorbance values at 460 nm.  
 
 
Scaffold Testing 
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Equipment: our device, PLGA scaffolds, 48 well plate, bone cells, nutrient media, CCK-8 assay, 
micropipette, gloves, 15 mL conicals, DI water 
Location and time: 192-328 (plating and incubation) and 33-394 (absorbance measurement) on 
Week 9.  
Procedure: 
1.) Obtain all equipment and sterilize if necessary.  
2.) Seed cells onto scaffolds according to the following: 
 -Five scaffolds will be used for each of our five test groups, totaling 25 scaffolds.  
 -There are four prong designs and one control group with no prongs, totaling five groups.  
 -Scaffolds must be placed in the wells on the plate that correspond to a specific prong 
design on our device.  
-Each scaffold will have 25000 cells. 
3.) Once plated, pipette 0.60 mL nutrient media into each well with scaffolds.  
4.) Cover well plate with our device and place in incubator at 37°C, 5% CO2 for 28 hours.  
5.) Remove plate from incubator, remove lid, and add 30 microliter of CCK-8 cellular assay to 
each well with scaffolds and media.  
6.) Place well plate in incubator for 3.5 hours. Remove well plate. 
7.) For wells of the same prong design, pool each of the five wells into a 15 mL conical using a 
pipette. You should now have five 15 mL conicals each with 3.0 mL of sample.  
8.) Cover the conicals with tinfoil and take them to the spectrophotometer.  
9.) Fill another conical with DI water and auto-zero the spectro at 460 nm: 
 -Turn on machine. 
 -Select ‘Spectra Manager’ -> ‘Time Management’ 
 -Place cuvette with water in spectro.  
 -Select ‘Parameters’ -> ‘Auto-zero’, and enter 460 nm for wavelength. 
10.) Empty one conical into a clean and dry cuvette being sure not to introduce any bubbles.   
11.) Take a ten second measurement of the sample and record average absorbance.  
12.) Repeat steps 10-11 for each sample. 
  
 
 
 
 
 
 
 
 
 
Scaffold Test Results 
Table 9: All scaffold test results, with our device. 
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Design Number of Small 
Prongs 
Base diameter 
(mm) 
Prong diameter 
(mm) 
Absorbance 
1 3 5 1.5 2.870 
2 3 5 2 2.334 
3 5 7 1.5 2.413 
4 6 7 2 2.164 
5 (Control) - - - 1.533 
Significance: PASS, our device was effective in promoting cellular proliferation as opposed to a 
normal well plate lid.  
 
 
Autoclave Testing 
The autoclave testing was performed to ensure the device was sterilizable and reusable per the 
customer specifications matrix. The autoclave testing was performed in 192-328 and Cardinal’s 
Lab. The equipment required was an autoclave, autoclave bag, indicator tape and calipers. Safety 
training was needed for access to 192-328. There was no training needed for use of the autoclave 
in Cardinal’s Lab, since Cardinal’s lab assistants ran the autoclave for us. The protocol 
performed for the autoclave testing is outlined below. 
1. Measure the distance between prongs for each of the 48 well inserts. Use calipers to 
measure the distance between the outside surfaces of two prongs. For the three pronged 
prong type, three measurements for prong distance should be taken. The measurement 
technique is shown in (A). For the five pronged prong type, two measurements should be 
taken for the prong distance(B) and two measurements should be taken for the six 
pronged prong type(C).  
2. Measure the diameter of the prong base for each well insert of the device. 
3. Measure the width, length and thickness of the top of the device 
4. The device was then placed in a bag and sealed. Indicator tape was placed on the top of 
the bag(C). The autoclave was set to run at a temperature of 210 degrees celsius for 6 
minutes. 
5. After autoclaving, the indicator strip color was examined to determine if an acceptable 
temperature for sterilization had been reached(D). 
6. The same measurement taken in steps 1-3 were then performed again. 
7. The measurements were then uploaded into minitab. 
8. A Turkey Comparison Test with a 95% confidence interval was performed to compare 
the prong distance, prong base and top(width,length and thickness) measurements before 
and after autoclaving.  
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9. The measurements from autoclave testing are shown in Appendix H. The statistical 
analysis is also shown below in Figures 2-4. There were no significant differences found 
for distance between prongs, prong base diameter and top dimensions before and after 
autoclaving for all of the four prong types.  
 
 
Figure 3: Autoclave testing measurement 
processes. (C) & (D) show the sterilization bag 
used.  
 
 
 
 
 
 
 
 
 
                
 
 
 
 
 
 
  
 
A B 
A 
D 
C 
B 
C D 
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C 
Figure 4: Anova Tukey Comparison testing with a 95% confidence interval for the distance 
between prongs for each prong type.(A) Statistical analysis for the three prong 1.5 mm diameter 
prong type.(B) Statistical Analysis for the three prong 2mm diameter prong type.(C) Statistical 
Analysis for the five prong 1.5 mm diameter prong type.(D) Statistical Analysis for the six prong 
2mm diameter prong type. 
 
 
 
Figure 5: Anova Tukey Comparison testing with a 95% confidence interval for the diameter of 
the prong base for each prong type.(A) Statistical analysis for the three prong 1.5 mm diameter 
prong type.(B) Statistical Analysis for the three prong 2mm diameter prong type.(C) Statistical 
C 
D 
B 
A 
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Analysis for the five prong 1.5 mm diameter prong type.(D) Statistical Analysis for the six prong 
2mm diameter prong type. 
Figure 6:Anova Tukey Comparison testing with a 95% confidence interval for the top dimension 
of the device(width, length and thickness). 
 
Significance: PASS, autoclave sterilization at 230°C for 5 minutes did not significantly warp or 
alter the dimensions of our device.  
 
 
Incubation Testing 
Incubation testing will be completed to ensure the dimensions of the device do not significantly 
change during incubation. Testing for incubation testing is performed in 192-328. The equipment 
needed is an incubator, well media, well plate and calipers. Safety training was need for access to 
192-328. The protocol for the incubation testing is outlined below. 
 
1.) Measure the distance between each prong for each of the 48 well inserts. Calipers are used to 
measure the distance between the outside surfaces of two prongs. For the three pronged prong 
type, three measurements for prong distance should be taken. The measurement technique is 
shown in Figure 2. For the five pronged prong type, two measurements should be taken for the 
prong distance(B) and two measurements should taken for the six pronged prong type(C).  
2.) Measure the diameter of the prong base for each well insert of the device. 
3.) Fill wells with cell media. 
4.) Place device on top of well plate. 
5.) Incubate for 72 hours at 37°C, 5% CO2. 
6.) Perform steps 1-3 again. 
A 
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B 
7.) Perform a Tukey Comparison Test with a 95% confidence interval to compare the prong 
distance, prong base and top(width,length and thickness) measurements before and after 
autoclaving.  
 
The measurements from incubation testing are shown in Appendix I. The statistical analysis is 
also shown below in Figures 7 and 8. There were no significant differences found for distance 
between prongs, prong base diameter and top dimensions before and after autoclaving for all of 
the four prong types.  
 
Figure 7: Anova Tukey Comparison testing with a 95% confidence interval for the 
distance between prongs for each prong type.(A) Statistical analysis for the three prong 1.5 mm 
diameter prong type.(B) Statistical Analysis for the three prong 2mm diameter prong type.(C) 
Statistical Analysis for the five prong 1.5 mm diameter prong type.(D) Statistical Analysis for 
the six prong 2mm diameter prong type. 
 
 
 
 
 
 
 
D 
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Figure 8: Anova Tukey Comparison testing with a 95% confidence interval for the 
diameter of the prong base for each prong type.(A) Statistical analysis for the three prong 1.5 
mm diameter prong type.(B) Statistical Analysis for the three prong 2mm diameter prong 
type.(C) Statistical Analysis for the five prong 1.5 mm diameter prong type.(D) Statistical 
Analysis for the six prong 2mm diameter prong type. 
 
Significance: PASS, incubation at 37°C, 5% CO2 for 72 hours did not significantly warp or alter 
the dimensions of our device.  
 
8.0 Conclusions and Recommendations 
 
8.1 Recommendations 
 Through trial and error we developed some recommendations for use. First, after printing 
there will be thin material strings going from prong to prong. These are leftover from printing 
and may interrupt the fit, since they are not part of the design. These imperfections and other 
sharp edges melt away during the autoclave process. We recommend our device be sterilized in 
the autoclave at 210C for at least 6 minutes. We sterilized our device at 260C as well and did not 
observe differences in dimensions. Once the print is done, we recommend it be left on the print 
bed for at least ten minutes to allow for complete cooling.  When placing on and removing the 
device from the well plate, each side must be raised simultaneously or the top surface can crack.  
 
8.2 Conclusions 
After testing, Nylon 6 proved to be a sterilizable material. Almost all warping comes 
from the printing process rather than the sterilization process. Slight warping may occur up to 
five minutes after the print. Warping our our device did not alter the dimensions or affect the fit 
on the well plate. We autoclaved our device three times and did not observe any dimension 
variation. Our tip design also proved effective. As long as the minimum prong diameter was 1.5 
mm, no deformation in prongs was observed during sterilization or incubation. All prongs on our 
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device generated more cell growth versus the control, with prong design #1 being the clear 
‘winner’. Our final device will be reprinted with uniform prongs of the following dimensions: 
Table 10: DOE Results to Determine Best Prong Choice 
 
Prong 
Design 
Number of Small 
Prongs 
Base diameter (mm) Prong diameter 
(mm) 
 
1 3 5 1.5 
2 3 5 2 
3 5 7 1.5 
4 6 7 2 
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10.2 Appendix B: Project Plan (PERT Chart) 
Figure 9: PERT chart and legend from Microsoft Project.  
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10.3 Appendix C: CAD Drawings 
All dimensions in millimeters. The differences between types 1 & 2 and between 3 & 4 
are base prong and small prong lengths, diameters are the same.  
 
Table 11: Specific prong type designs.  
 
 
 
 
 
 
 
 
 
 
Figure 6: SolidWorks drawing of device, all dim’s in mm.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Prong 
Design 
Number of Small 
Prongs 
Base diameter (mm) Prong diameter 
(mm) 
1 3 5 1.5 
2 3 5 2 
3 5 7 1.5 
4 6 7 2 
PLGA Scaffold Device  Powada, Tackabery, Morell   
 
30  BMED Senior Project Fall ’18-Winter ‘19 
 
10.4 Appendix D: FMEA, Hazard & Risk Assessment 
 
 Our testing provided some valuable insight on mitigating risks while manufacturing our 
device. Though we only performed autoclave testing at the required temperature, we did sterilize 
our device at various temperatures. Significant deformation was seen when sterilizing at 260°C 
for 15 minutes. Sterilization should be performed at either 210°C for 15 minutes or at 230°C for 
five minutes only. 1.5 mm diameter proved to be the best small prong design. This design is able 
to be efficiently manufactured, but the prongs can be broken off fairly easily by human hands. 
For this reason, the small prongs on the underside of the device should never be touched, unless 
absolutely necessary. All sharp or potentially dangerous edges on our device are nicely smoothed 
out during sterilization. The autoclave eliminates any left over, free hanging strands of material 
as well.  
 
Table 12: Risks and Hazards Assessment table. 
Hazard Planned Corrective Action 
Small and sharp edges on device Fillet design edges, machine down to smooth 
Small prongs can break off Enlarge prong diameter 
Material toxicity during incubation Change material  
Extreme incubation environment Change material or treat material surface prior 
to use 
Prongs fail to submerge scaffolds Change prong length 
 
Table 13: FMEA Assessment. 
Componen
t 
Name 
Possible 
Failure 
Mode Type 
Cause of 
Failure 
O
C
C 
D
E
T 
S
E
V 
R
P
N 
Effect of Failure 
on System 
Failure 
Improvement 
Alternative 
Actions (actions to 
fix the problem… ) 
Comment
s 
Base Fracture C,M Degradation of 
mechanical 
properties due to 
incubation and 
continuous use, 
parts not properly 
or fully joined 
1 3 3 9 Depending on 
level of breakage 
the scaffolds 
could be moved 
and cell 
proliferation 
could decrease 
causing the 
scaffolds to be 
Determine a 
lifespan for the 
product,ensure the 
material chosen has 
desirable 
mechanical 
properties for the 
lab environment. 
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useless. 
Prongs Bending M Unable to bear 
load of device 
1 2 6 12 Whole device 
could shift and 
spill the cell 
medium.The 
scaffolds could 
also be damaged. 
Choose a size,shape 
and material that 
will support the load 
of the device. 
 
          
 
Prong Degradat
ion,Fract
ure 
M Incubation could 
cause degradation 
of the mechanical 
properties material 
and potentially a 
fracture. 
3 4 6 72 Failure of the 
prong could result 
in perforation of 
the scaffold and 
for the scaffold to 
not be submerged 
in the cell 
medium. 
Choose a material 
with desirable 
mechanical 
properties for the 
lab environment. 
 
Material of 
Body and 
Prongs  
Toxicity, 
Expansio
n 
M Incubation could 
lead to toxic 
particles from the 
material 
interaction with 
the cell medium or 
expansion of the 
parts. 
4 1 9 32 Toxicity could 
affect the growth 
of the cells. 
Expansion of the 
components could 
lead to movement 
of the device or 
fracture. 
Choose a material 
with a low 
coefficient of 
thermal expansion. 
Choose a material 
that is 
biocompatible. 
 
Material of 
Tip 
Mechani
cal stress 
on cells 
M Damage the 
scaffolds, 
negatively affect 
cell growth 
3 1 9 18 Reacting with the 
scaffolds could 
lead to changes in 
cell growth 
Choose an inert 
material and create 
a testing protocol to 
ensure it doesn't 
negatively affect 
cell growth.  
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10.5 Appendix E: Pugh Chart 
 
Concept 1: Well plate lid with base and prongs projecting into wells 
Concept 2: Semipermeable membrane/cage housing scaffolds 
Concept 3: Bioreactor completely separate from well plate  
 
Table 14: All pugh charts. Concept ideas seen above.  
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10.6 Appendix F: Vendor Information, Specifications, and Data Sheets 
Nylon 6 material:  
 
 
Ultimaker 3D Printer: 
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CCk-8 assay:  
 
 
 
10.7 Appendix G: Budget 
Table 15: Budget Outline for Project 
Product Distributor Cost Unit Amount Details Product Number For 
Nylon 6 3D Universe 40.49 each 1 
750 g spool of 2.85 
mm filament 
KODAK_NY63N
ON 
Manufacturing 
Garolite 
sheet 
McMaster 
Carr 
10.68 each 1 6" x 6" 1/32" thick 9910T59 Manufacturing 
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CCK-8 Sigma 64 each 3 100 test pack 96992 
Proliferation 
testing 
Food 
coloring 
Target 3.95 each 1 
dropper bottle red 
dye 
- 
Proliferation 
testing 
  247.12      
*Garolite sheet was not used. The slightly different Garolite sheet listed in 5.4 is the proper one 
necessary for future manufacturing.  
 
10.8 Appendix H: Autoclave Raw Data 
 
Table 14: Distance Between Prongs Before Autoclave 
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Table 15: Base Diameter of each Prong Before Autoclave 
 
 
 
 
 
 
 
 
Table 16: Measurements of the Top of the Device Before Autoclave 
 
 
 
 
Table 17: Distance Between Prongs After Autoclave 
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Table 18: Base Diameter of Each Prong After Autoclave 
 
 
 
 
 
 
 
Table 19: Measurements of the Top of the Device After Autoclave 
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10.9 Appendix I:Incubation Raw Test Data 
 
Table 20: Distance Between Prongs Before Incubation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 21: Base Diameter of Each Prong Before Incubation 
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Table 22: Measurements of the Top of the Device Before Incubation 
 
 
 
 
Table 23: Distance Between Prongs After Incubation 
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Table 24: Base Diameter of Each Prong After Incubation 
 
 
 
Table 25: Measurements of the Top of the Device After Incubation 
 
 
 
 
 
 
